Role of aberrant crypt foci in understanding the pathogenesis of colon cancer

Cancer Letters

Volumn 93, Issue 1, 1995, Pages 55-71

  Bird, Ranjana P ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; COLON CARCINOGENESIS; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INTESTINE CRYPT; NONHUMAN; PRECANCER; PRIORITY JOURNAL;

1,2-DIMETHYLHYDRAZINE; ADENOCARCINOMA; ADENOMA; ANIMAL; AZOXYMETHANE; CARCINOGENS; CHOLIC ACID; CHOLIC ACIDS; COLON; COLONIC NEOPLASMS; DIETARY FATS; DIMETHYLHYDRAZINES; GENES, RAS; HUMAN; INTESTINAL MUCOSA; PRECANCEROUS CONDITIONS; SUPPORT, NON-U.S. GOV'T;

ANIMALIA; RODENTIA;

EID: 0029003648     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(95)03788-X     Document Type: Article

References (90)

1. Report of the AIN ad hoc committee on standards for nutrition studies
2. Second report of the ad hoc committee on standards for nutrition studies
3. Aberrant crypt foci and microadenoma as marker for colon cancer
4. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings
5. Effect of cholic acid on the number and growth of aberrant crypt foci: putative preneoplastic lesions
6. Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon
7. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer
8. Animal models for the study of nutrition and human disease: colon cancer, atherosclerosis, and osteoporosis
9. Letter to the Editor
10. Aberrant crypt foci in the detection of colon carcinogens
11. Diet, aberrant crypt foci and colorectal cancer
12. Effect of dietary carbohydrates on the growth of dysplastic crypt foci in the colon of rats treated with 1,2-dimethylhydrazine
13. Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice
14. Histogenesis of colon cancer in experimental animals
15. Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats
16. Promotion of colonic microadenoma growth in mice and rats fed cooked sugar or cooked casein and fat
17. Experimentally induced cancer of the colon
18. Colonic neoplasms in mice produced with six injections of 1,2-dimethylhydrazine
19. Susceptibility to 1,2-dimethylhydrazine-induced colonic tumors and epithelial cell proliferation characteristics of F1, F2, and reciprocal backcrosses derived from SWR/J and AKR/J parental mouse strains
20. Some emerging general principles in the pathogenesis of hepatocellular carcinoma
21. Clonal adaptation as an important phase of hepatocarcinogenesis
22. The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens
23. Cellular adaptation in the origin and development of cancer
24. Progressing toward a molecular description of colorectal cancer development
25. Animal models in the study of colorectal cancer
26. Demonstration of the need for end point validation of putative biomarkers: failure of aberrant crypt foci to predict colon cancer incidence
27. Chemical and physical carcinogenesis: advances and perspectives for the 1990s
28. Molecular determinants of dysplasia in colorectal lesions
29. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechic acid
30. Dietary cholesterol enhances preneoplastic aberrant crypt formation and alters cell proliferation in the murine colon treated with azoxymethane
31. Pathology of colorectal adenomas: a colonoscopic survey
32. Effect of dietary fat on colonic protein kinase C and induction of aberrant crypt foci
33. Reduction of aberrant crypt formation in the colon of CF1 mice by potential chemopreventive agents
34. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention
35. Histogenesis of colorectal carcinoma
36. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid
37. Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid
38. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid
39. Aberrant crypts: potential preneoplastic lesions in the murine colon
40. Specificity study to evaluate induction of aberrant crypts in murine colons
41. Effect of disulfiram on 1,2-dimethylhydrazine- and azoxymethane-induced aberrant crypt foci
42. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions
43. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon
44. Nuclear organizer region-associated proteins in cancer cells
45. The evolution of cancer of the colon and rectum
46. Use of azoxymethaneinduced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents
47. Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon
48. Morphology and morphogenesis of experimental epithelial tumors of the intestine
49. Aberrant crypts: putative preneoplastic foci in human colonic mucosa
50. Colonic aberrant crypts in azoxymethane treated F344 rats have decreased hexosaminidase activity
51. Aberrant crypts in human colonic mucosa: putative preneoplastic lesion
52. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate
53. K-ras mutations in putative preneoplastic lesions in human colon
54. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon
55. Dietary cholesterol enhances the induction and development of colonic preneoplastic lesions in C57BL/6J and BALB/CJ mice treated with azoxymethane
56. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon
57. Large-bowel carcinogenesis: fecal concentrations of populations with diverse incidence rats of colon cancer
58. Dysplasia in inflammatory bowel disease standardized classification with provisional clinical applications
59. Effects of high corn oil diet on preneoplastic murine colons: prostanoid production and lipid composition
60. Measurement of the proliferative status of colonic epithelium as a risk marker for colon carcinogenesis: effect of bile acid and dietary fibre
61. Early events in human colorectal carinogenesis. Aberrant crypts and microadenoma
62. Classification of aberrant crypt foci and microadenomas in human colon
63. Identification and quantification of aberrant crypt foci and microadenomas in the human colon
64. Characterization of stereo-microscopically identified preneoplastic lesions during dimethlyhydrazine-induced colonic carcinogenesis
65. In vivo induction of colon cancer, dose and animals species
66. Carcinoma in situ in nonpolypoid mucosa of the large intestine
67. A correlation of argyrophyllic nuclear organizer regions with stages of hepatocellular carcinoma
68. Usefulness of nuclear organizer region staining in gastric myogenic tumors: correlation with ploidy by DNA flow cytometry
69. Variable effect of cholic acid on the induction and growth of aberrant crypt foci and colonic tumors in Sprague Dawley rats
70. The effect of high-risk and low-risk diets on aberrant crypt and colonic tumor formation in Fischer-344 rats
71. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane induced colon carcinogenesis
72. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons
73. Sucrose enhancement of the early steps of colon carcinogenesis in mice
74. Expression of ras oncogene mRNA and protein in aberrant crypt foci
75. Colonic aberrant crypt foci are associated with increased expression of c-fos: the possible role of modified c-fos expression in preneoplastic lesions in colon cancer
76. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of colon cancer
77. Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci
78. Multiple genetic alterations in human carcinogenesis
79. The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon
80. Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid
81. Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine
82. Aberrant elevation of tyrosine-specific phosphorylation in human gastric cancer cells
83. Influence of a dietary fiber on development of dimethylhydrazine-induced aberrant crypt foci and colon tumor incidence in Wistar rats
84. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods
85. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis
86. Genetic alterations during colorectal-tumor development
87. Comparative histogenesis and pathology of naturally-occuring human and experimentally induced large bowel cancer in the rat
88. Growth kinetics and chemoprevention of aberrant crypts in the rat colon
89. Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein